Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen- presenting cells

American Journal of Pathology

Volumn 150, Issue 2, 1997, Pages 641-651

  Nestle, Frank O ^a   Burg, Günter ^a   Fäh, Jürg ^a   Wrone Smith, Tamara ^b   Nickoloff, Brian J ^b,c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR3 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTING CELL; ARTICLE; BASAL CELL CARCINOMA; DENDRITIC CELL; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SKIN DISEASE; T LYMPHOCYTE;

ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CARCINOMA, BASAL CELL; DENDRITIC CELLS; HLA-DR ANTIGENS; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASMS, RADIATION-INDUCED; SKIN NEOPLASMS; SUNLIGHT; T-LYMPHOCYTES;

EID: 0031024123     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991, 9:271-296
2. Romani N, Koide S, Crowley M, Witmer-Pack M, Living-stone AM, Fathman CG, Inaba K, Steinman RM: Presentation of exogenous protein antigen by dendritic cells to T cell clones: intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 1989, 169:1169-1175
3. Inaba K, Metlay JP, Crowley M T, Steinman RM: Dendritic cells pulsed with protein antigen in vitro can prime antigen-specific MHC-restricted T cells in-situ. J Exp Med 1990, 172:631-640
4. Boon T, Cerottini J-C, Eynde BVD, Bruggen PVD, Pel AV: Teaching the immune system to fight cancer. Annu Rev Immunol 1994, 12:337-365
5. Forni GM, Giovarelli F, Cavallo M, Consalvo A: Cytokine induced tumor immunogenicity: from exogenous cytokines to gene therapy, J Immunother 1993 14:253-257
6. Tipper RJ, Mule JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 1994, 5:153-161
7. June CH, Bluestone JA, Nadler LM, Thompson CB: The B7 and CD28 receptor families. Immunol Today 1994, 15:321-331
8. + T cells by B7 transfected melanoma cells. Science 1993, 259:368-370
9. Chen L, Linsley PS, Hellström KE: Co-stimulation of T cells for tumor immunity, Immunol Today 1993, 14:483-486
10. Bogdan C, Vodovotz Y, Nathan CF: Macrophage deactivation by interleukin 10. J Exp Med 1991, 174:1549-1554
11. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG, Kiessling R: Interleukin 10 pretreatment protects target cells from tumor and allospecific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 1994, 180:2371-2377
12. Grimwood RE: Immune Mechanisms in Cutaneous Disease. Edited by DA Norris. New York, Marcel Dekker, 1989, pp 789-799
13. Hunt, MJ, Halliday GM, Weedon D, Cooke BE, Barnetson RS: Regression in basal cell carcinoma: an immunohistochemical analysis. Br J Dermatol 1994, 130:1-8
14. Buechner SA: Intralesional interferon-α2b in the treatment of basal cell carcinoma. J Am Acad Dermatol 1991, 24:731-734
15. Kim J, Modlin RL, May R, Dubinett SM, McHugh T, Nickoloff BJ, Uyemura K: 1L-10 production in cutaneous basal and squamous cell carcinomas: a mechanism for evading the local T cell immune response. J Immunol 1995, 155:2240-2247
16. Mitra RS, Judge TA, Nestle FO, Turka LA, Nickoloff BJ: Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10: differential modulation of B7-1 (CD80) and B7-2 (CD86) expression. J Immunol 1995, 154:2668-2677
17. Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamade H, Pardoll D, Mulligan RC: Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993, 90:3539-3543
18. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H: Role of bone marrow derived cells in presenting MHC class l-restricted tumor antigens. Science 1994, 264:961-965
19. Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ: Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinct subsets, J Immunol 1993, 151:6535-6545 (Erratum 152:376)
20. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 1994, 180:83-93
21. Nestle F, Thompson C, Shimizu Y, Turka LA, Nickoloff BJ: Costimulation of superantigen-activated T lymphocytes by autologous dendritic cells is dependent on B7. Cell Immunol 1994, 156:220-229
22. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM: B-cell surface antigen B7 provides a co-stimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 1993, 90:6586-6590
23. Harding FA, McArthur JG, Gross JA, Raulet DA, Allison JP: CD28 mediated signaling co-stimulates murine T cells, and prevents induction of anergy in T cell clones. Nature 1992, 365:607-609
24. Streilein JW: Dermal cells: underappreciated components of skin-associated lymphoid tissue (SALT). Dermal Immune System, Edited by BJ Nickoloff. Boca Raton, FL, CRC Press, 1994, pp 25-28
25. Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD: IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol 1995, 154:1280-1286
26. Beissert S, Ullrich SE, Hosoi J, Granstein RD: Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content. J Leukocyte Biol 1995, 58:234-240
27. Kripke ML, Cox PA, Alas LG, Yarosh DB: Pyrimidine dimers in DNA initiate immunosuppression in UV-irradiated mice. Proc Natl Acad Sci USA 1992, 89:7516-7520
28. Rivas JM, Ulrich, SE: Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells, J Immunol 1992, 149:3865-3871
29. Streilein JW, Taylor JR, Vincek V, Kurimoto I, Shimizu T, Tie C, Golomb C: Immune surveillance and sunlight-induced skin cancer. Immunol Today 1994, 15:174-179
30. Smith DR, Kunkel SL, Burdick MD, Wilke CA, Orringer MB, Whyte RI, Strieter RM: Production of interleukin-10 by human bronchogenic carcinoma. Am J Pathol 1994, 145:18-25
31. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Hardini CV: Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993, 361:359-362
32. Nestle FO, Turka LA, Nickoloff BJ: Characterization of dermal dendritic cells in psoriasis: autostimulation of T lymphocytes and induction of Th-1 type cytokines. J Clin Invest 1994, 94:202-209
33. Markowicz S, Engleman EG: Granulocyte-macrophage colony stimulating factor promotes differentiation and survival of human blood dendritic cells in vitro. J Clin Invest 1990, 85:955-963
34. Larsen CP, Ritchie SC, Hendrix R, Linsley PS, Hathcock KS, Hodes RJ, Lowry RP, Pearson TC: Regulation of immunostimulatory function and co-stimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994, 152:5208-5219
35. Pardoll DM: Cancer vaccines. Immunol Today 1993, 14:310-316
36. Nestle FO, Büchner S, Nickoloff BJ, Burg G: Induction of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) on peritumor antigen-presenting cells in basal cell carcinomas treated with interferon-α. J Invest Dermatol 1995, 105:492
37. Tykocinski ML, Kaplan DR, Medof ME: Antigen-presenting cell engineering: the molecular toolbox. Am J Pathol 1996, 148:1-16
38. Huang AYC, Bruce AT, Pardoll DM, Levitsky HI: Does B7-1 expression confer antigen-presenting cell capacity to tumors In vivo? J Exp Med 1996, 183:769-776